Abstract:Interleukin 5 (IL-5) is a specific cytokine involved in the development and differentiation of eosinophils. I t plays an important role in diseases associated with increased levels of eosinophils, such as asthma and atopic dermatitis.',? W: have solved the three-dimensional structure of human 1L-5 to a resolution of 2.4 A using X-ray crystallographic techniques. The molecule is a dimer of identical subunits that are joined together by disulphide bridges. The crystal structure reveals a novel two-domain structure where each domain of the protein is a 4-helical bundle containing two short stretches of beta sheet. These domain structures show a high degree of similarity to the cytokine fold, which has already been described in Interleukin-2 and -4, granulocyte, and granulocyte-macrophage colony stimulating factors, and porcine and human growth hormones. This high degree of similarity within known cytokine structures has led us to make predictions of the structures of cytokines for which no three-dimensional information is available. Furthermore, it provides the molecular basis for the design of agonists and antagonists of IL-5, which will be important in the therapy of eosinophil mediated diseases. 1L-5 is a T-cell-derived cytokine that causes eosinophilpoesis and activation of eosinophils. In order to investigate its biology and its role in models of asthmatic inflammation, we have produced the protein in large quantities. A synthetic gene for human IL-5 was overexpressed in E . coli, where the protein forms inclusion bodies. This protein can then be subsequently renatured under carefully controlled conditions of protein concentration and buffer redox potential to give large quantities of active p r ~ t e i n . ~ Unlike the natural human IL-5, the E. coli derived material is not glycosylated. It is of equal potency, however, showing that glycosylation is not required for biological activity. We mapped the positions of the disulphide

Structure‐Function analysis of human IL‐6: Identification of two distinct regions that are important for receptor binding

Structure‐function analysis of human IL‐6 receptor: dissociation of amino acid residues required for IL‐6‐binding and for IL‐6 signal transduction through gp130.

Structure-function analysis of human interleukin-2. Identification of amino acid residues required for biological activity.

Three-dimensional Structure and Function Study on the Active Region in the Extracellular Ligand-Binding Domain of Human IL-6 Receptor

Function and molecular modeling of the interaction between human interleukin 6 and its HNK-1 oligosaccharide ligands

Homology Modeling of the Functional Domain of the Extracellular Region of Human Il-6 Receptor.

Active Regions’ Setting of the Extracellular Ligandbinding Domain of Human Interleukin-6 Receptor

Unveiling novel insights into human IL-6 - IL-6R interaction sites through 3D computer-guided docking and systematic site mutagenesis

Two modes of beta-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3

Progress in the Research of Structure and Function of Interleukin-6 Receptor

Homology modeling of the functional domain of the extracellular region of human 1L-6 receptor

The Structure of Interleukin-2 Complexed with Its Alpha Receptor

The Three‐Dimensional Structure of Human Interleukin‐5 at 2.4‐Angstroms Resolution: Implication for the Structures of Other Cytokines

Expression and Biological Activity Analysis of Human Soluble IL-6R and Its Mutant

Molecular modeling of the three-dimensional structure of the human interleukin-11

Structure of the Quaternary Complex of Interleukin-2 with Its [alpha], {szligbeta}, and [gamma][subscript C] Receptors

Expression, Purification and Characterization of Soluble Human Interleukin-6 Receptor Α-Chain and Its Mutant Protein in Escherichia Coli

Advances in Structural Base of Interaction Between Hil-6 and Its Receptor and Antagonist of Hil-6

Structure and Assembly of the Human IL-12 Signaling Complex

Prediction on the Binding Domain Between Human Interleukin-6 and Its Receptor

Structure of the Quaternary Complex of Interleukin-2 with Its Alpha, Beta, and Gammac Receptors.